Takeda psoriasis drug gets FDA priority review
Takeda (NYSE:TAK) said the U.S. FDA accepted its New Drug Application for zasocitinib under Priority Review for adults with moderate-to-severe plaque psoriasis.
Takeda (NYSE:TAK) said the U.S. FDA accepted its New Drug Application for zasocitinib under Priority Review for adults with moderate-to-severe plaque psoriasis.
Novo Nordisk (NYSE:NVO) launched a corporate rebrand that will see the company use the shorter “Novo” name in day-to-day communications while retaining Novo Nordisk A/S as its legal name.
Exploration company Albion Resources (ASX:ALB) has commenced a maiden 7,000-metre drilling programme at its Gidgee Gold Project.
OneSteel Manufacturing will reduce its Whyalla steelworks workforce from 1,700 to 1,200 following the permanent shutdown of an unrepairable blast furnace.
Connected Minerals (ASX:CML) has commenced a 6,000m drilling programme at its Bailundo Carbonatite Project in Angola.
Rumble Resources (ASX:RTR) announced scheduled exploration programmes across three of its Western Australian gold and base metal projects.
DroneShield (ASX:DRO) has announced plans to combine its DroneSentry detection platform with AIM Defence's Fractl high-power laser technology.
Eastern Gas (ASX:EGA) completed drilling operations and demobilisation at its Venus-2H well site.
Entropy Neurodynamics (ASX:ENP) reported positive Phase 2 trial results for its intravenous psilocin drug TRP-8803.
Globe Metals & Mining (ASX:GBE) secured full legal clearance to progress its Kanyika Niobium Project.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy